Table 1 Patient characteristics
Patients | Age/Sex | Tumor site* | Prior therapy** | Peptide | |
|---|---|---|---|---|---|
Primary | Metastases | (mg) | |||
1 | 38/F | IBD | Lung, bone | Ope, GEM, CBDCA, TS-1, DTX | 1 |
2 | 69/M | GB | Liver, LN | Ope, GEM, TS-1 | 1 |
3 | 60/F | GB | Liver, LN | Ope, GEM, TS-1 | 1 |
4 | 66/F | IBD | Liver, lung, LN, bone | Ope, GEM, TS-1 | 2 |
5 | 75/M | IBD | Lung | Ope, GEM, TS-1 | 2 |
6 | 61/F | IBD | Liver, LN, peritoneum | GEM, TS-1, CDDP | 2 |
7 | 46/M | EBD | Liver, LN | Ope, GEM, TS-1 | 3 |
8 | 76/M | EBD | Lung | Ope, GEM, TS-1 | 3 |
9 | 62/F | EBD | Lung | Ope, GEM, TS-1 | 3 |